Siemens Healthineers stock: EUR 43.32, down 1.14% premarket
Published on 11/20/2026 at 08:18 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSWhat Siemens Healthineers Investors Watch
- Siemens Healthineers develops medical technology, services and solutions for clinical decision-making and treatment pathways.
- The company is scheduled to publish its fiscal 2026 annual report on November 25.
- Fiscal fourth-quarter results were released on November 5, keeping the 2027 outlook in focus.
Siemens Healthineers stock traded at 43.32 euros on Lang & Schwarz at 08:14 CET on Friday, November 20, 2026, 1.14 percent below the Xetra close of 43.82 euros on Thursday, November 19, 2026.
The company develops medical technology, services and solutions used in clinical decision-making and treatment pathways. Its portfolio spans imaging, diagnostics, cancer care and minimally invasive therapies, giving investors exposure to healthcare capital spending and hospital workflows.
Annual Report Sets Next Date
Siemens Healthineers is scheduled to publish its fiscal 2026 annual report on Wednesday, November 25, according to the company's investor-relations calendar. The company released its fiscal fourth-quarter results on November 5.
The upcoming publication gives investors a near-term reference point for the fiscal 2026 performance and management's outlook for fiscal 2027. The latest company materials also list a healthcare investor event in Chicago on November 30.
German equities are tracked in the DAX market environment.
